• 1. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 2. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829

Recent Advances in the Synthesis and Applications of 7-Amino-3-chloro-3-cephem-4-carboxylic acid (CAS: 53994-69-7)

7-Amino-3-chloro-3-cephem-4-carboxylic acid (CAS: 53994-69-7) is a key intermediate in the synthesis of cephalosporin antibiotics, a class of β-lactam antibiotics widely used to treat bacterial infections. Recent studies have focused on optimizing its synthesis, exploring its biological activity, and developing novel derivatives with enhanced therapeutic properties. This research briefing provides an overview of the latest advancements related to this compound, highlighting its significance in the pharmaceutical industry.

A recent study published in the Journal of Medicinal Chemistry (2023) demonstrated an improved synthetic route for 7-Amino-3-chloro-3-cephem-4-carboxylic acid, achieving higher yields and purity compared to traditional methods. The researchers utilized a combination of enzymatic catalysis and green chemistry principles, reducing the environmental impact of the synthesis process. This advancement is particularly relevant given the growing demand for sustainable pharmaceutical manufacturing practices.

In terms of biological applications, a 2024 study in Antimicrobial Agents and Chemotherapy investigated the compound's potential as a scaffold for developing new antibiotics against multidrug-resistant Gram-negative bacteria. The research team synthesized several derivatives of 7-Amino-3-chloro-3-cephem-4-carboxylic acid and evaluated their antibacterial activity, identifying two promising candidates with potent activity against carbapenem-resistant Enterobacteriaceae (CRE).

Structural analysis of 7-Amino-3-chloro-3-cephem-4-carboxylic acid and its derivatives has also been a focus of recent research. X-ray crystallography studies published in Acta Crystallographica Section D (2023) provided detailed insights into the molecular interactions between these compounds and bacterial penicillin-binding proteins (PBPs), offering valuable information for structure-based drug design.

The pharmaceutical industry has shown increasing interest in this compound, with several patent applications filed in 2023-2024 for novel synthetic methods and therapeutic applications. One notable development is its potential use in combination therapies, where it serves as a precursor for cephalosporins designed to work synergistically with β-lactamase inhibitors.

Quality control and analytical methods for 7-Amino-3-chloro-3-cephem-4-carboxylic acid have also seen advancements. A 2024 publication in the Journal of Pharmaceutical and Biomedical Analysis presented a validated HPLC method for the simultaneous determination of this compound and its potential impurities, addressing the need for robust quality assurance in API manufacturing.

Looking forward, researchers are exploring the potential of 7-Amino-3-chloro-3-cephem-4-carboxylic acid beyond traditional antibiotic applications. Preliminary studies suggest its derivatives may have applications in anticancer therapies and as modulators of the gut microbiome, though these areas require further investigation.

• 36923-17-8(7-Amino-3-cephem-4-carboxylic Acid)
• 22252-43-3(7-Aminodeacetoxycephalosporanic acid)
• 70356-03-5(Cefaclor hydrate)
• 64753-81-7(5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[(aminophenylacetyl)amino]-3-chloro-8-oxo-, [6R-(6a,7b)]- (9CI))
• 53994-73-3(cefaclor)
• 26395-99-3(7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid)
• 15690-38-7(7-Amino-deacetylcephalosporanic Acid)
• 56871-82-0(5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-amino-3-methyl-8-oxo-, monosodium salt, (6R,7R)- (9CI))
• 127431-38-3((6S)-7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
• 127388-96-9(5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(chloromethyl)-7-(formylamino)-8-oxo-, (6R,7R)-)